Subhash Chauhan to Benzopyrans
This is a "connection" page, showing publications Subhash Chauhan has written about Benzopyrans.
Connection Strength
2.361
-
Chauhan N, Maher DM, Hafeez BB, Mandil H, Singh MM, Yallapu MM, Jaggi M, Chauhan SC. Ormeloxifene nanotherapy for cervical cancer treatment. Int J Nanomedicine. 2019; 14:7107-7121.
Score: 0.621
-
Khan S, Ebeling MC, Chauhan N, Thompson PA, Gara RK, Ganju A, Yallapu MM, Behrman SW, Zhao H, Zafar N, Singh MM, Jaggi M, Chauhan SC. Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer. Cancer Res. 2015 Jun 01; 75(11):2292-304.
Score: 0.457
-
Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT, Thompson PA, Balabathula P, Behrman SW, Zafar N, Singh MM, Halaweish FT, Jaggi M, Chauhan SC. Nanoparticle formulation of ormeloxifene for pancreatic cancer. Biomaterials. 2015; 53:731-43.
Score: 0.456
-
Maher DM, Khan S, Nordquist JL, Ebeling MC, Bauer NA, Kopel L, Singh MM, Halaweish F, Bell MC, Jaggi M, Chauhan SC. Ormeloxifene efficiently inhibits ovarian cancer growth. Cancer Lett. 2015 Jan 28; 356(2 Pt B):606-12.
Score: 0.442
-
Chauhan N, Maher DM, Yallapu MM, B Hafeez B, Singh MM, Chauhan SC, Jaggi M. A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth. Sci Rep. 2019 07 29; 9(1):10917.
Score: 0.154
-
Hafeez BB, Ganju A, Sikander M, Kashyap VK, Hafeez ZB, Chauhan N, Malik S, Massey AE, Tripathi MK, Halaweish FT, Zafar N, Singh MM, Yallapu MM, Chauhan SC, Jaggi M. Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic ?-catenin Signaling and EMT Progression. Mol Cancer Ther. 2017 10; 16(10):2267-2280.
Score: 0.133
-
Gara RK, Sundram V, Chauhan SC, Jaggi M. Anti-cancer potential of a novel SERM ormeloxifene. Curr Med Chem. 2013; 20(33):4177-84.
Score: 0.098